Marshall Wace’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-574,050	Closed	-$5.71M	–	3963
2021 Q3	$5.71M	Buy	574,050 +23,862	+4%	+$237K	0.02%	767
2021 Q2	$5.44M	Buy	+550,188	New	+$5.44M	0.02%	709